Chemotherapy & More
- This forum has 1,151 topics, 3,414 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary,
- 1
- 1
- 2 years, 4 months ago
- Gene mutational profile of BRCAness and clinical implication in predicting respo
- 1
- 1
- 2 years, 4 months ago
- Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoa
- 1
- 1
- 2 years, 5 months ago
- Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intr
- 1
- 1
- 2 years, 5 months ago
- Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepat
- 1
- 1
- 2 years, 5 months ago
- Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Ad
- 1
- 1
- 2 years, 5 months ago
- TAIHO ONCOLOGY ANNOUNCES UPDATED EFFICACY AND SAFETY DATA FOR FUTIBATINIB IN CHO
- 1
- 1
- 2 years, 5 months ago
- A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully T
- 3
- 6
- 2 years, 5 months ago
- Toripalimab combined with gemcitabine and S-1 in the first-line treatment of adv
- 1
- 1
- 2 years, 5 months ago
- Adjuvant gemcitabine plus cisplatin (GemCis) versus capecitabine (CAP) in patien
- 1
- 1
- 2 years, 5 months ago
- PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib
- 1
- 1
- 2 years, 5 months ago
- Gemcitabine plus cisplatin versus non-gemcitabine and cisplatin regimens as neoa
- 1
- 1
- 2 years, 5 months ago
- NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemc
- 1
- 1
- 2 years, 5 months ago
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.